Differential expression and function of AR isoforms in prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The androgen receptor (AR) is crucial in prostate cancer (PCa) development.
• Two AR isoforms, AR-A and AR-B, exist, differing in their N-terminal domain.
• Limited knowledge exists regarding AR-A/B isoform expression and function in PCa.

Purpose of the Study:

• To analyze the association between AR-A, AR-B, and their ratio with prostate cancer.
• To investigate the functional roles of AR-A and AR-B in PCa cell lines.

Main Methods:

• Western blot and immunofluorescence to quantify AR-A and AR-B levels in prostate tissues.
• Analysis of AR-A/B ratios in relation to Gleason scores.
• Transfection of PC3 cells with AR or AR-A expression vectors to study isoform function.

Main Results:

• AR-A, AR-B, and the AR-A/B ratio were elevated in PCa tissues compared to benign prostatic hyperplasia (BPH) and normal prostate.
• Elevated AR-A/B ratios correlated with higher Gleason scores.
• Overexpression of AR-A and AR-B reduced PC3 cell invasion and proliferation.
• AR-A overexpression further decreased proliferation but increased invasion compared to AR-B.

Conclusions:

• Increased AR-A, AR-B, and AR-A/B ratio are linked to prostate cancer occurrence and progression.
• AR-A shows potential as a therapeutic target for PCa due to its effects on cell invasion and proliferation.
• This study enhances understanding of AR-A/AR-B interactions and their impact on PCa treatment.